Muro 128 5%

Drug Overview

In the highly technical field of Ophthalmology, the clarity of the eye’s “front window” depends entirely on its state of relative dehydration. Muro 128 5% is a high-potency pharmacological agent belonging to the Hypertonic Saline drug class. As a hyperosmotic solution, it is the more concentrated counterpart to the 2% formulation, designed for more aggressive management of fluid accumulation within the corneal layers.

As a Targeted Therapy for corneal endothelial dysfunction, Muro 128 5% acts as a molecular “pump” that assists a failing cornea. It is primarily utilized for patients whose cornea has become thickened and hazy due to conditions where the natural fluid-drainage mechanisms of the eye are compromised.

• Generic Name: Sodium Chloride Hypertonic (5%)
• Brand Name: Muro 128
• Drug Category: Ophthalmic Hyperosmotic
• Route of Administration: Topical Ophthalmic Drops (Solution) or Ointment
• FDA Approval Status: FDA-approved as an Over-the-Counter (OTC) medication for the temporary relief of corneal edema.

What Is It and How Does It Work? (Mechanism of Action)

To understand how Muro 128 5% functions, one must examine the “endothelial pump.” The innermost layer of the cornea (the endothelium) is responsible for pumping water out to keep the cornea transparent. When these cells are damaged or diseased, water builds up in the corneal stroma, causing “Corneal Edema.”

Muro 128 5% functions at the molecular and physiological level via an osmotic gradient:

1. Hypertonicity: The 5% concentration is significantly higher than the salt concentration of natural human tears (which is roughly 0.9%).
2. Osmotic Flux: According to the laws of physics, water moves from an area of low solute concentration to an area of high solute concentration. When the 5% drop is applied, it creates a “saltier” environment on the eye’s surface.
3. Corneal Dehydration: This gradient “pulls” excess fluid out of the waterlogged corneal tissues (epithelium and stroma) and into the tear film, where it can be blinked away.
4. Optical Restoration: As the fluid is removed, the organized structure of the corneal collagen is restored, reducing light scattering and clearing the “morning fog” typically associated with corneal swelling.

FDA-Approved Clinical Indications

Primary Indication

The primary FDA-approved indication for Muro 128 5% is the Temporary Relief of Corneal Edema. It is the standard-of-care for clearing vision when the cornea becomes cloudier due to fluid retention.

Other Approved & Off-Label Uses

The osmotic power of 5% saline is utilized across several complex Ophthalmology scenarios:

• Fuchs’ Endothelial Dystrophy: Managing chronic edema caused by the progressive loss of endothelial cells.
• Bullous Keratopathy: Reducing the size of “bullae” (painful fluid blisters) on the corneal surface.
• Post-Operative Management: Clearing swelling after cataract surgery or Corneal Transplants (DSEK/DMEK).
• Recurrent Corneal Erosion (RCE): Used off-label (especially the ointment form at night) to “shrink” the epithelial cells, allowing them to bond more tightly to the underlying tissue to prevent painful “rips” upon waking.
• Acute Glaucoma Stabilization: Temporarily clearing a “steamy” cornea caused by a sudden spike in Intraocular Pressure (IOP) to allow for better surgical visualization.

Dosage and Administration Protocols

Because the 5% concentration is highly potent, it is often used as a “loading dose” in the morning or as a protective barrier at night.

Formulation	Standard Dose	Frequency
5% Solution (Drops)	1 to 2 drops	Every 3 to 4 hours (as needed)
5% Ointment	Small ribbon (1/4 inch)	Once daily at bedtime
RCE Prophylaxis	Ointment	Once daily at bedtime

Specific Instructions for Administration:

• The “Bite”: Be prepared for a sharp stinging sensation. This is normal for a 5% salt solution.
• Punctal Occlusion: Gently press the inner corner of the eye for 1 minute after instillation. This ensures the salt stays on the cornea rather than draining into the throat.
• Ointment Use: The 5% ointment causes significant blurring. It should only be applied immediately before sleep.
• Wait Time: If using other medications, such as VEGF Inhibitors or glaucoma drops, wait at least 10 minutes between applications.
• Contact Lenses: Avoid wearing contact lenses while using hypertonic saline; the salt can dehydrate and “shrink” the lens, causing corneal damage.

Clinical Efficacy and Research Results

Clinical data through 2026 confirms that 5% hypertonic saline is significantly more effective at reducing corneal thickness than the 2% formulation.

Numerical Efficacy Data:

• Corneal Thinning: Research using Optical Coherence Tomography (OCT) has shown that 5% saline can reduce central corneal thickness by 40 to 80 microns within 60 minutes.
• Visual Acuity (BCVA): Patients with moderate Fuchs’ Dystrophy often see an improvement of 2 or more lines of Best Corrected Visual Acuity (BCVA) on a Snellen chart after morning application.
• RCE Success: Clinical studies show that 5% ointment at bedtime reduces the recurrence of corneal erosions by over 50% in chronic sufferers.
• OCT Monitoring: Physicians now use high-definition OCT to track the resolution of “sub-epithelial fluid,” showing that the 5% concentration effectively collapses these pockets of fluid.

Safety Profile and Side Effects

Black Box Warning: There is NO Black Box Warning for Muro 128.

Common Side Effects (>10%)

• Intense Stinging/Burning: This is the hallmark side effect. The 5% solution has a high osmotic “pull” that can be painful for the first 30 seconds.
• Hyperemia: Temporary redness of the white of the eye.
• Tearing: The eye may water profusely as a reflex to the salt.

Serious Adverse Events (Rare)

• Corneal Irritation: In eyes with very thin corneas, the high salt content can cause further surface breakdown if not used as directed.
• Preservative Sensitivity: Some patients may react to the Benzalkonium Chloride (BAK) or Parabens used in the multi-dose bottles.

Management Strategies:

To reduce stinging, some patients find relief by keeping the drops in the refrigerator. If the 5% drops are intolerable, a specialist may recommend the 5% ointment, which often stings less due to its petroleum base.

Research Areas

Direct Clinical Connections

Active research (2024–2026) is investigating the drug’s impact on Aqueous Outflow Resistance. Scientists are studying whether the osmotic changes on the corneal surface can subtly improve fluid movement in the anterior chamber. There is also research into how 5% saline protects the Retinal Pigment Epithelium (RPE) by ensuring the eye remains clear enough for surgeons to perform retinal monitoring.

Generalization

The field of Ophthalmology is moving toward Novel Delivery Systems for hyperosmotic therapy:

• Preservative-Free Multi-dose Bottles: Engineering bottles that protect the 5% solution without the use of harsh chemicals.
• Gel-Forming Solutions: Research into “liquid-to-gel” drops that provide the osmotic power of the 5% solution with the long residency time of the ointment.
• Sustained-Release Inserts: Miniature wafers placed in the lower lid that release salt slowly over 12 hours.

Disclaimer: The research discussed regarding the effect of hyperosmotic therapy on aqueous outflow resistance, the development of liquid-to-gel formulations, and the investigation of slow-release inserts for salt delivery is currently in the investigational or preclinical phase and is not yet applicable to standard clinical practice. 

Patient Management and Clinical Protocols

Pre-treatment Assessment

• Baseline Diagnostics: Visual Acuity and OCT (Pachymetry) to measure corneal thickness.
• Slit-lamp Exam: Checking for “epithelial bullae” or signs of active infection.
• IOP Check: High eye pressure can worsen edema; therefore, monitoring Intraocular Pressure (IOP) is essential.

Monitoring and Precautions

• Vigilance: If the eye becomes severely painful or if vision suddenly drops, the patient must contact their doctor immediately.
• Lifestyle:
  • Hair Dryer Technique: Using a hair dryer at arm’s length on a “cool” setting can help evaporate fluid from the eye alongside Muro 128 use.
  • UV Protection: Sunglasses are recommended as swollen corneas are highly sensitive to light.
• Do’s and Don’ts:
  • DO use the ointment at night for the best “de-swelling” effect in the morning.
  • DO discard the bottle if the solution becomes cloudy.
  • DON’T touch the dropper tip to your eyelashes.

Legal Disclaimer

This guide is for informational purposes only and does not constitute medical advice. Muro 128 5% is an OTC medication, but chronic corneal edema is a serious medical condition. Always consult a licensed Ophthalmologist or healthcare provider before beginning a treatment regimen. Information is current as of April 2026.